SG
RMD icon

Societe Generale’s ResMed RMD Stock Holding History

Societe Generale’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$5.99M Buy
+94,795
New +$5.59M 0.04% 346

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Societe Generale's RMD Position: Q2 2016 in Review

Societe Generale opened a new position in ResMed (RMD) in Q2 2016: 94,795 shares worth $5.99M. The stake represents 0.04% of the portfolio and ranks #346 among its holdings.

361 funds tracked by Wall St. Rank hold RMD as of Q2 2016.

  • Societe Generale held 94,795 shares of ResMed worth $5.99M as of Q2 2016.
  • ResMed was a new Societe Generale position in Q2 2016.
  • ResMed made up 0.04% of Societe Generale's portfolio in Q2 2016, its #346 holding.
  • 361 funds tracked by Wall St. Rank held ResMed as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.